Physiological analysis of the role of PACAP using transgenic and knockout mice
Physiological analysis of the role of PACAP using transgenic and knockout mice
批准号:
12470016
负责人:
BABA Akemichi
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
本研究利用本实验室新培育的PACAP基因敲除小鼠(PACAP^<;-/->;)、胰腺高表达PACAP的转基因小鼠(PACAP-TG)和PACAP(PAC_1)受体外显子2靶向的小鼠(PAC_1^<;-/->;),研究了内源性PACAP在中枢和外周神经系统中的生理和病理生理作用。通过这些体内诱变研究,我们获得了以下结果。精神运动功能(1)PACAP^<;-/->;;小鼠在旷野表现出过度活跃和爆炸性跳跃行为,探索性行为增加,焦虑减少。这些异常行为可被抗精神病药物和SSRI改善。(2)PACAP小鼠表现出明显的脉冲前抑制声惊厥反应的损害。这些结果提供了PACAP在精神运动行为调节中发挥先前未知的作用的证据,并表明PACAP小鼠的表型在一定程度上类似于人类的sc…更多的精神分裂症和/或注意力缺陷/多动障碍(ADHD)。海马区功能PACAP^<;-/->;小鼠和PAC_1^<;-/->;小鼠表现出海马长时程增强(LTP)的损害。此外,行为学研究还揭示了海马区依赖联想学习的缺陷,暗示PACAP能神经元参与了高级脑功能的调节。疼痛传递神经病理性和炎症性疼痛模型中的痛觉过敏和痛觉过敏在PACAP^<;-/->;小鼠中显著减少。PACAP^<;-/->;小鼠视交叉上核(SCN)中光诱导的时相重置和c-Fos表达减弱,凸显了PACAP在体内对昼夜节律性光携带的作用。血糖和胰岛素稳态(1)转基因PACAP改善链脲佐菌素诱导的糖尿病。值得注意的是,在链脲佐菌素治疗的PACAP-TG小鼠中,5-溴-2-脱氧尿苷(BrdU)阳性的β细胞增加。(2)我们将PACAP-TG小鼠与致死的黄色kka^y小鼠杂交,这是一种肥胖-糖尿病的遗传模型。Kka^y小鼠表现出明显的高血糖,并伴有代偿性高胰岛素血症和胰岛增生;然而,在携带PACAP转基因的kka^y小鼠中,高胰岛素血症和胰岛增生都显著受到抑制。本研究结果表明,PACAP对I型糖尿病和肥胖相关(II型)糖尿病具有保护作用,并可能参与了β细胞的新生。这是首次报道PACAP在体内对胰岛增殖和β细胞新生的作用,为与PACAP信号通路相关的药物治疗糖尿病提供了可能性。较少
英文摘要
This study examined the physiological and pathophysiological roles of endogenous PACAP in the central and peripheral nervous system using PACAP gene knockout (PACAP^<-/->) mice, transgenic mice overexpressing PACAP in the pancreas (PACAP-Tg), and PACAP (PAC_1) receptor exon 2-targeted (PAC_1^<-/->) mice which were recently generated in this laboratory. Through these in vivo mutagenesis studies, we obtained the following results.1. Psychomotor function(1) PACAP^<-/-> mice exhibited hyperactive and explosive jumping behaviors in an open field, and increased exploratory behavior and less anxiety. These aberrant behaviors are ameliorated by the antipsychotic drug and SSRI.(2) PACAP^<-/-> mice exhibited a significant impairment of prepulse inhibition of the acoustic startle response.These results provide evidence that PACAP plays a previously uncharacterized role in the regulation of psychomotor behaviors and suggest that the phenotype of PACAP^<-/-> mice in part resembles those in human sc … More hizophrenia and/or attention deficit/hyperactivity disorder (ADHD).2. Hippocampal functionPACAP^<-/-> mice and PAC_1^<-/-> mice showed an impairment of hippocampal long-term potentiation (LTP). In addition, the behavioral study revealed a deficit in hippocampus-dependent associative learning, implicating PACAP-ergic neurons in regulation of higher brain functions.3. Pain transmissionAllodynia and hyperalgesia in the neuropathic and inflammatory pain models were significantly reduced in PACAP^<-/-> mice.4. Circadian rhythmThe light-induced phase resetting and c-Fos expression in the suprachiasmatic nucleus (SCN) were attenuated in PACAP^<-/-> mice, highlighting the in vivo role of PACAP in circadian photoentrainment.5. Glucose and insulin homeostasis(1) The PACAP transgene ameliorated streptozotocin-induced diabetes in PACAP-Tg mice. Notably, an increase in 5-bromo-2-deoxyuridine (BrdU)-positive β cells in the streptozotocin-treated PACAP-Tg mice was observed.(2) We crossed PACAP-Tg and lethal yellow KKA^y mice, a genetic model for obesity-diabetes. KKA^y mice showed marked hyperglycemia associated with compensatory hyperinsulinaemia and islet hyperplasia; however, both hyperinsulinemia and islet hyperplasia were significantly suppressed in KKA^y mice carrying the PACAP transgene.The present data suggest a protective role for PACAP against type I diabetes as well as obesity-associated (type II) diabetes, and the possible involvement of PACAP in the β cell neogenesis. This is the first report suggesting in vivo roles of PACAP on islet hyperplasia and β cell neogenesis, providing the possibility that drugs associated with PACAP-signaling pathways might be of therapeutic value for the treatment of diabetes. Less
期刊论文(166)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hannes Reuter, Scitt A.: "Knockout Mice for Pharmacological Screening Testing the Specificity of Na^+ -Ca^<2+> Exchange Inhibitors"Circ Res.. 91・2. 90-92 (2002)
Hannes Reuter,Schitt A.:“用于药理学筛选的敲除小鼠测试 Na^+ -Ca^<2+> 交换抑制剂的特异性”Circ Res.. 91・2 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yukio Ago: "Selective reduction by isolation rearing of 5-HT_<1A> receptor-mediated dopamine release in vivo in the frontal cortex of mice"J.Neurochem.. 83・2. 353-359 (2002)
前幸雄:“通过隔离饲养选择性减少小鼠额叶皮层体内5-HT_<1A>受体介导的多巴胺释放”J.Neurochem.. 83・2(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuhiro Takuma: "Heat Shock inhibits hydrogen peroxide-induced apoptosis in cultured astrocytes"Brain Res.. 946(2). 232-238 (2002)
Kazuhiro Takuma:“热休克抑制培养的星形胶质细胞中过氧化氢诱导的细胞凋亡”Brain Res.. 946(2)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
馬場明道: "神経ペプチド、PACAP:現状と展望"脳21. 4. 324-327 (2001)
Akimichi Baba:“神经肽,PACAP:现状和前景” Brain 21. 4. 324-327 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toshio Matsuda: "SEA0400, a Novel and Selective Inhibitor of the Na+-Ca2+ Exchanger, Attenuates Reperfusion Injury in the in Vitro and in Vivo Cerebrial Ischemic Models"J.Pharmacol.Exp.Ther. 298・1. 249-256 (2001)
Toshio Matsuda:“SEA0400,一种新型选择性 Na+-Ca2+ 交换剂,可减轻体外和体内脑缺血模型的再灌注损伤”J.Pharmacol.Exp.Ther. 298・1。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 68 条
Functional analyses of novel mitochondrial fusion inhibitor HPGBin the regulation of heart and metabolism
-
批准号:23659143
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:BABA Akemichi
-
依托单位:
Molecular basis study on PACAP gene as a risk factor for schizophrenia
-
批准号:21390069
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2009
-
负责人:BABA Akemichi
-
依托单位:
Molecular basis on function and clinical implication of neuropeptide PACAP
-
批准号:18209009
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.28万
-
财政年份:2006
-
负责人:BABA Akemichi
-
依托单位:
Molecular pharmacological aspects of the neuropeptide PACAP in brain and pancreas
-
批准号:15209009
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2003
-
负责人:BABA Akemichi
-
依托单位:
Research and Development of Neuroprotective Drugs Based on the Neuron-Glia Interactions
-
批准号:11557004
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:BABA Akemichi
-
依托单位:
Molecular mechanisms of glial activation and cell death
-
批准号:09470504
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:1997
-
负责人:BABA Akemichi
-
依托单位:
Study on the possibility for drug utilization of peptidergic neurotransmitter using knockout mouse
-
批准号:07557157
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$10.75万
-
财政年份:1995
-
负责人:BABA Akemichi
-
依托单位:
Neuropharmacological studies on the roles of glial receptors for neurotransmitters in gliosis
-
批准号:05454149
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1993
-
负责人:BABA Akemichi
-
依托单位:
Establishment of in vitro screenin models for new drugs against brain edema
-
批准号:04557124
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$2.94万
-
财政年份:1992
-
负责人:BABA Akemichi
-
依托单位:
Regulation of glutamate neurotransmission by endogenous Zn^<++>
-
批准号:02454136
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.78万
-
财政年份:1990
-
负责人:BABA Akemichi
-
依托单位:
Neuropharmacological study on excitatory amino acid receptors in hippocampus
-
批准号:61570103
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1986
-
负责人:BABA Akemichi
-
依托单位:
海外基金